Every figure this model derived for BIO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.
This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.
| Figure | Value | XBRL tag | As at |
|---|---|---|---|
| capex | 139,500,000 | PaymentsToAcquirePropertyPlantAndEquipment |
2026-06-30 |
| cash | 1,618,500,000 | CashAndCashEquivalentsAtCarryingValue |
2026-06-30 |
| current assets | 3,020,500,000 | AssetsCurrent |
2026-06-30 |
| current liabilities | 961,300,000 | LiabilitiesCurrent |
2026-06-30 |
| equity | 7,173,900,000 | StockholdersEquity |
2026-06-30 |
| interest expense | 48,800,000 | InterestExpense |
2026-06-30 |
| ocf | 492,600,000 | NetCashProvidedByUsedInOperatingActivities |
2026-06-30 |
| revenue | 2,589,300,000 | RevenueFromContractWithCustomerExcludingAssessedTax |
2026-06-30 |
| sbc | 60,300,000 | ShareBasedCompensation |
2026-06-30 |
The figures themselves rather than their scores — what somebody looking up BIO on one particular measure came for.
| Ratio | Value |
|---|---|
| cash operating margin | 10.54 |
| current ratio | 3.32 |
| current ratio reported | 3.14 |
| deferred revenue growth | -3.49 |
| dilution pct | -3.31 |
| ebit cagr | -48.57 |
| ebit yoy | -82.45 |
| ev ebit | 210.62 |
| ev owner earnings | 33.95 |
| ev sales | 3.84 |
| fcf margin | 13.64 |
| growth cv | 13.44 |
| interest cover | 0.97 |
| operating margin | 1.82 |
| owner earnings margin | 11.31 |
| revenue growth | 1.37 |
| revenue growth per share | 4.84 |
| roic | 0.55 |
| rule of 40 | 3.2 |
| sbc pct revenue | 2.33 |
What this model itself distrusts about BIO's figures. Written by the derivation as it ran, not added afterwards.